These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27999070)

  • 1. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    Boerma RS; Sigaloff KC; Akanmu AS; Inzaule S; Boele van Hensbroek M; Rinke de Wit TF; Calis JC
    J Antimicrob Chemother; 2017 Feb; 72(2):365-371. PubMed ID: 27999070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.
    Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS
    J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
    Kuhn L; Hunt G; Technau KG; Coovadia A; Ledwaba J; Pickerill S; Penazzato M; Bertagnolio S; Mellins CA; Black V; Morris L; Abrams EJ
    AIDS; 2014 Jul; 28(11):1673-8. PubMed ID: 24785949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria.
    Inzaule SC; Osi SJ; Akinbiyi G; Emeka A; Khamofu H; Mpazanje R; Ilesanmi O; Ndembi N; Odafe S; Sigaloff KCE; Rinke de Wit TF; Akanmu S
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):e1-e7. PubMed ID: 28961680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis.
    Takem EN; Coox C; Shang J; Ndongmo C; Dokubo EK
    PLoS One; 2024; 19(4):e0300456. PubMed ID: 38626183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis.
    Jordan MR; Penazzato M; Cournil A; Vubil A; Jani I; Hunt G; Carmona S; Maphalala G; Mthethwa N; Watera C; Kaleebu P; Musanhu CC; Mtapuri-Zinyowera S; Dzangare J; Peeters M; Yang C; Parkin N; Bertagnolio S
    Clin Infect Dis; 2017 Nov; 65(12):2018-2025. PubMed ID: 29020335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    Boender TS; Hamers RL; Ondoa P; Wellington M; Chimbetete C; Siwale M; Labib Maksimos EE; Balinda SN; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Stevens W; Rinke de Wit TF; Sigaloff KC
    J Infect Dis; 2016 Sep; 214(6):873-83. PubMed ID: 27402780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.
    Silverman RA; Beck IA; Kiptinness C; Levine M; Milne R; McGrath CJ; Bii S; Richardson BA; John-Stewart G; Chohan B; Sakr SR; Kiarie JN; Frenkel LM; Chung MH
    J Infect Dis; 2017 Dec; 216(12):1569-1578. PubMed ID: 29040633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
    Gupta RK; Gregson J; Parkin N; Haile-Selassie H; Tanuri A; Andrade Forero L; Kaleebu P; Watera C; Aghokeng A; Mutenda N; Dzangare J; Hone S; Hang ZZ; Garcia J; Garcia Z; Marchorro P; Beteta E; Giron A; Hamers R; Inzaule S; Frenkel LM; Chung MH; de Oliveira T; Pillay D; Naidoo K; Kharsany A; Kugathasan R; Cutino T; Hunt G; Avila Rios S; Doherty M; Jordan MR; Bertagnolio S
    Lancet Infect Dis; 2018 Mar; 18(3):346-355. PubMed ID: 29198909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
    Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
    J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa.
    le Roux SM; Abrams EJ; Nguyen K; Myer L
    Trop Med Int Health; 2016 Jul; 21(7):829-45. PubMed ID: 27125333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011.
    Ladner J; Besson MH; Rodrigues M; Saba J; Audureau E
    PLoS One; 2015; 10(6):e0130103. PubMed ID: 26098311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta-analysis.
    Macdonald V; Mbuagbaw L; Jordan MR; Mathers B; Jay S; Baggaley R; Verster A; Bertagnolio S
    J Int AIDS Soc; 2020 Dec; 23(12):e25656. PubMed ID: 33369131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pretreatment HIV drug resistance in Mwanza, Tanzania.
    Rudovick L; Brauner JM; Englert J; Seemann C; Plugaru K; Kidenya BR; Kalluvya SE; Scheller C; Kasang C
    J Antimicrob Chemother; 2018 Dec; 73(12):3476-3481. PubMed ID: 30165451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017.
    Kang RH; Liang SJ; Ma YL; Liang S; Xiao L; Zhang XH; Lu HY; Xu XQ; Luo SB; Sun XG; Chen L; He JM; Wu GH; Liao LJ; Xing H; Shao YM; Ruan YH
    Infect Dis Poverty; 2020 May; 9(1):54. PubMed ID: 32448388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program.
    Nassali M; Nakanjako D; Kyabayinze D; Beyeza J; Okoth A; Mutyaba T
    AIDS Care; 2009 Sep; 21(9):1124-31. PubMed ID: 20024771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.